2 completed, 1 recruiting, 1 unknown. 3 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Biopharma Plasma LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID) BP-SCIG 20% - Primary Immunodeficiency Diseases | Phase 3 | Recruiting | Biopharma Plasma LLC | 56 | 2025-12-17 | 2026-01-16 |
| Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults Intravenous immunoglobulin (IVIG), 10% solution for infusion - Primary Immune Thrombocytopenia | Phase 3 | Completed | Biopharma Plasma LLC | 32 | 2022-07-26 | 2024-09-23 |
| Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women Human Anti-D (rh) immunoglobulin - Pregnancy Related | Phase 4 | Unknown | Biopharma Plasma LLC | 281 | 2022-02-08 | 2024-04-18 |
| Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment IVIG - Covid19, Pneumonia | Phase 3 | Completed | Biopharma Plasma LLC | 76 | 2020-05-07 | 2020-10-14 |
COVID-19 (1) · Coronavirus Infections (1) · Pneumonia (1) · Primary Immunodeficiency Diseases (1) · Purpura, Thrombocytopenic, Idiopathic (1)
Immunoglobulins, Intravenous (2) · Administration, Intravenous (1) · Immunoglobulins (1) · Rh-Hr Blood-Group System (1) · Solutions (1) · gamma-Globulins (1)
Ukraine (4)